Intravenous ketamine
Sponsors
The Brooklyn Hospital Center, Rebecca Price, University of Ottawa, University of Alabama at Birmingham, Assiut University
Conditions
AnaesthesiaAnalgesiaBipolar DepressionCesarean SectionChildren, OnlyDeep SedationDepressionDepression, Unipolar
Phase 1
Intravenous Ketamine Plus Neurocognitive Training for Depression
CompletedNCT03237286
Start: 2017-12-01End: 2022-10-18Updated: 2024-03-19
Repeated Neurocognitive Measurements in Depressed Patients
CompletedNCT04916548
Start: 2021-09-16End: 2023-08-15Updated: 2024-08-20
Ketamine + Mindfulness for Depression
CompletedNCT05168735
Start: 2022-02-01End: 2023-09-01Updated: 2024-08-20
Repeated Neurocognitive Measurements in Depressed Patients
WithdrawnNCT05991232
Start: 2025-05-01End: 2029-04-01Updated: 2026-02-25
Phase 3
Phase 4
Ketamine v. Ketorolac for Management of Generalized Tension Type Headache
NCT03221569
Start: 2016-02-01End: 2020-02-01Target: 60Updated: 2018-07-06
Intranasal Versus Intravenous Ketamine for Procedural Sedation in Children With Non-operative Fractures
TerminatedNCT03781817
Start: 2019-09-09End: 2022-04-30Updated: 2023-04-20
Ketamine + Cognitive Training for Suicidality in the Medical Setting: Pilot
TerminatedNCT04154150
Start: 2019-12-19End: 2022-03-15Updated: 2024-07-22
Ketamine + Cognitive Training for Suicidality in the Medical Setting
Active, not recruitingNCT04578938
Start: 2021-03-15End: 2026-12-02Updated: 2026-03-24
Study between Femoral Nerve Block and Intravenous Ketamine in Pain Management for Elderly Patients with Femur Fracture during Positioning before Spinal Anesthesia
Active, not recruitingPACTR202112605652525
Start: 2020-01-22Target: 66Updated: 2026-06-22
IV and Intrathecal Ketamine in Cesarean Section
CompletedNCT05679375
Start: 2023-02-01End: 2024-10-31Updated: 2025-03-06